drugset / Trial / NCT01586975
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.
Timeline
- Start
- 2007-07
- Primary completion
- 2010-04
- Completion
- 2011-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 81 mg | — |
| Comparator | Aspirin | Small molecule | 300 mg | — |
| Comparator | Clopidogrel | Small molecule | 75 mg | — |